Comments on: Nanobiotix Announces Presentation of Part 1 Data From a Randomized Phase 2 Clinical Trial Evaluating JNJ-1900 (NBTXR3) in Stage 3 Inoperable Lung Cancer https://thegbm.com/nanobiotix-announces-presentation-of-part-1-data-from-a-randomized-phase-2-clinical-trial-evaluating-jnj-1900-nbtxr3-in-stage-3-inoperable-lung-cancer/ Business news, opinion, reviews, interviews Sun, 17 May 2026 14:15:00 +0000 hourly 1 https://wordpress.org/?v=6.9.4